Supercharging Co-Development Of Therapeutics & Companion Diagnostics 

Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit

The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.

Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.

Snapshot of Our 2023 Expert Speaker Faculty:

Highlights of Last Year's World Clinical Biomarkers & CDx Summit

View the 2023 Event Guide Here

brochure

Download your copy to find the 2023 speakers, full agenda breakdown, partners, accessing the best possible rates and to see how biopharma & academia can secure their FREE pass

Our 2023 Partners

Other Events in the Series